abstract |
The present invention relates to a complex comprising an engineered polypeptide having affinity for interleukin-6 (IL-6) and an antibody or antigen-binding fragment thereof, wherein the engineered polypeptide having affinity for IL-6 Belongs to any of the engineered polypeptides comprising the sequence < RTI ID = 0.0 > EEX 3 X 4 AWX 7 EIHX 11 LPNLX 16 X 17 X 18 QX 20 X 21 AFIX 25 X 26 LX 28 X 29 . The invention also relates to the use of said complexes for therapy. |